AN OPEN-LABEL, SINGLE-DOSE, PHARMACOKINETICS STUDY OF VALTOCO® WITH OPEN-LABEL SAFETY PERIOD IN PEDIATRIC SUBJECTS WITH EPILEPSY
Clinical Trial Grant
Administered By
Pediatrics, Neurology
Awarded By
Neurelis, Inc
Start Date
August 10, 2022
End Date
April 30, 2024
Administered By
Pediatrics, Neurology
Awarded By
Neurelis, Inc
Start Date
August 10, 2022
End Date
April 30, 2024